Philadelphia, PA, United States of America

Jin Liu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Southern California. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Liu. Retrieved from https://idiyas.com/inventor/jin-liu-3c3xki54

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jin Liu - Innovator in Pancreatic Research

Introduction

Jin Liu is a prominent inventor based in Philadelphia, PA. He has made significant contributions to the field of pancreatic research, particularly in the area of pancreatic stromal progenitor cells. His work has implications for the treatment of diabetes mellitus, showcasing his commitment to advancing medical science.

Latest Patents

Jin Liu holds a patent related to pancreatic stromal progenitor cells. This patent encompasses the isolation of these cells, as well as a composition that includes them. Furthermore, it details a treatment method that involves administering this composition to patients. The focus on diabetes mellitus highlights the potential impact of his research on a widespread health issue.

Career Highlights

Jin Liu is affiliated with the University of Southern California, where he continues to engage in groundbreaking research. His work has garnered attention for its innovative approach to addressing complex medical challenges. With a patent portfolio that includes 1 patent, he is recognized for his contributions to the scientific community.

Collaborations

Jin Liu collaborates with fellow researcher Songtao Shi, enhancing the scope and depth of their research endeavors. Their partnership exemplifies the collaborative spirit that drives innovation in the field of medical research.

Conclusion

Jin Liu's work in pancreatic stromal progenitor cells represents a significant advancement in diabetes treatment. His innovative research and collaboration with other experts underscore the importance of continued exploration in this vital area of health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…